Your browser doesn't support javascript.
loading
Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial.
Kim, Nam Hoon; Lim, Soo; Kwak, Soo Heon; Moon, Min Kyong; Moon, Jun Sung; Lee, Yong-Ho; Cho, Ho Chan; Lee, Juneyoung; Kim, Sin Gon.
Afiliação
  • Kim NH; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Lim S; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National Bundang Hospital, Seongnam, Korea.
  • Kwak SH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Moon MK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Moon JS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Lee YH; Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea.
  • Cho HC; Departmentof Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.
  • Lee J; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Kim SG; Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.
BMJ Open ; 8(9): e022448, 2018 09 24.
Article em En | MEDLINE | ID: mdl-30249630

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Adamantano / Complicações do Diabetes / Diabetes Mellitus Tipo 2 / Dipeptídeos / Quimioterapia Combinada / Glucosídeos / Metformina Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Adamantano / Complicações do Diabetes / Diabetes Mellitus Tipo 2 / Dipeptídeos / Quimioterapia Combinada / Glucosídeos / Metformina Idioma: En Ano de publicação: 2018 Tipo de documento: Article